These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Lycium barbarum polysaccharide stimulates proliferation of MCF-7 cells by the ERK pathway.
    Author: Shen L, Du G.
    Journal: Life Sci; 2012 Sep 24; 91(9-10):353-7. PubMed ID: 22921303.
    Abstract:
    AIMS: The aim of this study was to investigate the anti-proliferative effect of Lycium barbarum polysaccharide (LBP) on MCF-7 cells. MAIN METHODS: MCF-7 cells were treated with 0, 10, 30, 100, and 300 μg/ml LBP for 24 h. The cell cycle distribution was analyzed by flow cytometry. MEK inhibitor, U1206 also was added in MCF-7 cells to deal with LBP (300 μg/ml) for different times (0, 2, 4, 6, 8, 16, 24 h). Western blotting was used to indicate changes in the levels of ERK (extracellular signal-regulated protein kinase) and phosphorylation-ERK (p-ERK) to compare the relationship between ERK activity and LBP. The expressions of p53, p-p53 and p21 were observed by western blotting to analyze the relationship between p53 and ERK which was under the treatment of LBP. KEY FINDINGS: The MCF-7 cell cycle was arrested in S phase with the treatment of LBP. The LBP can also activate ERK, which may be associated with p53 pathway. There was a dose-dependent increase in the relation between the degree of ERK activation and LBP. SIGNIFICANCE: LBP induces the anti-proliferation of MCF-7 cells by activating ERK.
    [Abstract] [Full Text] [Related] [New Search]